dihexa pnb-0408 c-met hgfr activator Drug development of MET inhibitors: targeting oncogene addiction and expedience dihexa solution stability data ·
dihexa solution stability data Disguised Alpha Dihexa (PNB 0408) c Met HGFR Activator Pancreatic Cancer Treatment Targeting the HGF c MET Pathway: The MEK Inhibitor Trametinib Targeting HGF c MET signaling to regulate the tumor microenvironment: Implications for counteracting tumor immune evasion PMC DIHEXA PEPTIDE 10MG VIAL UMBRELLA Labs
Pay in 4 interest-free payments of $6.54 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10



